Skip to content

Acquisitions at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.5B
Stryker logo
StrykerSYK
-$481M-840%
Globus Medical logo
Globus MedicalGMED
$4.91M-1.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$284.25K
Enovis logo
EnovisENOV
$291K-98.5%
OrthoPediatrics logo
OrthoPediatricsKIDS
$6.78M

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$18.52B-1.4%
Enterprise value$25.57B-0.9%
P/E24.3×+1.5×
P/S2.2×-0.2×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessTwoNetOfCashAcquired.

The official record: Zimmer Biomet Holdings’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's acquisitions?
Zimmer Biomet Holdings (ZBH) reported acquisitions of $166.9M in Q4 2025.
How has Zimmer Biomet Holdings's acquisitions changed year-over-year?
Zimmer Biomet Holdings's acquisitions increased by 4.3% year-over-year, from $160M to $166.9M.
What is the long-term trend for Zimmer Biomet Holdings's acquisitions?
Over 2 years (2022 to 2024), Zimmer Biomet Holdings's acquisitions has grown at a 66.4% compound annual growth rate (CAGR), from $99.8M to $276.3M.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.